Prio Wealth Limited Partnership’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$483K Hold
1,979
0.01% 194
2024
Q2
$379K Hold
1,979
0.01% 209
2024
Q1
$392K Hold
1,979
0.01% 209
2023
Q4
$340K Hold
1,979
0.01% 205
2023
Q3
$293K Hold
1,979
0.01% 213
2023
Q2
$432K Hold
1,979
0.02% 198
2023
Q1
$433K Hold
1,979
0.02% 191
2022
Q4
$412K Hold
1,979
0.02% 196
2022
Q3
$432K Hold
1,979
0.02% 191
2022
Q2
$415K Hold
1,979
0.02% 200
2022
Q1
$480K Hold
1,979
0.02% 193
2021
Q4
$515K Hold
1,979
0.02% 198
2021
Q3
$522K Sell
1,979
-208
-10% -$56.9K 0.02% 190
2021
Q2
$539K Sell
2,187
-37
-2% -$7.78K 0.02% 190
2021
Q1
$432K Sell
2,224
-50
-2% -$10K 0.02% 201
2020
Q4
$483K Buy
2,274
+245
+12% +$48.9K 0.02% 191
2020
Q3
$348K Hold
2,029
0.01% 201
2020
Q2
$390K Buy
2,029
+50
+3% +$8.18K 0.02% 185
2020
Q1
$291K Hold
1,979
0.02% 195
2019
Q4
$307K Hold
1,979
0.01% 216
2019
Q3
$267K Hold
1,979
0.01% 223
2019
Q2
$241K Buy
+1,979
New +$219K 0.01% 224

Other funds holding RMD

Prio Wealth Limited Partnership's RMD Position: Q3 2024 in Review

Prio Wealth Limited Partnership held its ResMed (RMD) position steady in Q3 2024 at 1,979 shares worth $483K. The position accounts for 0.01% of the portfolio, ranked #194.

Prio Wealth Limited Partnership first reported a position in RMD in Q2 2019 and has held it in 22 quarters since. The position peaked at $539K in Q2 2021. 801 funds tracked by Wall St. Rank hold RMD as of Q3 2024.

  • Prio Wealth Limited Partnership held 1,979 shares of ResMed worth $483K as of Q3 2024.
  • Prio Wealth Limited Partnership left its ResMed share count unchanged in Q3 2024.
  • ResMed made up 0.01% of Prio Wealth Limited Partnership's portfolio in Q3 2024, its #194 holding.
  • Prio Wealth Limited Partnership first reported a position in ResMed in Q2 2019 and has held it in 22 quarters since.
  • Prio Wealth Limited Partnership's ResMed position peaked at $539K in Q2 2021.
  • 801 funds tracked by Wall St. Rank held ResMed as of Q3 2024.

Based on Prio Wealth Limited Partnership's 13F filing for Q3 2024, filed 21 Oct 2024.